Epigenetics Market is Expected to Reach 1.6 billion by 2025: Illumina, Inc., Abcam plc., Thermo Fisher Scientific Inc., Zymo Research Corp, Active Motif Corporation, QIAGEN N.V., New England Biolabs, Inc., Merck KGaA, CellCentric, Eisai Co., Ltd. and Nova

Industry Trend Analysis
The global epigenetics market is expected to be around 1.6 billion by 2025. The market is primarily driven by factors such as increase in research activities related to epigenetics, increasing collaborations between biotechnology companies, pharmaceutical companies and academic as well as research institutions and rising prevalence of cancer around the world. According to the National Cancer Institute under the U.S. Department of Health and Human Services, between 2012 and 2030, new cancer cases around the world are expected to increase by 50% from 14 million to 21 million. As per American Cancer Society’s 2017 report, around 1.7 million new cancer cases will be diagnosed in 2017 in the U.S. With such significant prevalence of cancer, the demand for advanced epigenetics research activities is expected to increase considerably in coming years.

Product Outlook and Trend Analysis
Kits segment held the major share of the global epigenetics market in 2016 owing to their large scale adoption for conducting epigenetics research by research organizations as well as biotechnology and pharmaceutical companies. Different kits used for epigenetics research include RNA sequencing kits, whole-genome amplification kits, bisulfite conversion kits and chip-seq kits among others.

Get Sample Copy of This Report@ https://www.qurateresearch.com/report/sample/HnM/QBI-CMR-HnM-54995

Research Area Outlook and Trend Analysis
Oncology segment held the largest share of the global epigenetics market in 2016 due to increasing demand for cancer research to mitigate the rising incidence of different forms of cancer around the world. However, drug discovery segment is expected to grow with a significant growth rate during the forecast period owing to varied applications of epigenetics in drug development for different diseases such as inflammatory and autoimmune diseases among other types.

Regional Outlook and Trend Analysis
In 2016, North America dominated the global epigenetics market owing to the availability of advanced research infrastructure in the region coupled with increasing funding targeted towards research and development in the field of epigenetics. However, Asia-Pacific epigenetics market is expected to witness fastest growth during the forecast period due to increasing healthcare expenditure and presence of unmet medical needs in emerging countries.

Competitive Outlook and Trend Analysis
The major players operating in the global epigenetics market focus on leveraging technological advancements in epigenetics research to develop improved products which can assist researchers in analyzing different disease etiologies. For instance, in May 2017, Epigentek Group Inc., a New York based biotechnology company, introduced its ELISA kits to be used in circulating histone modifications for colorimetric measurement. The introduction of the new kit was intended towards strengthening the histone modification assays portfolio of the company. Some of the key players operating in the global epigenetics market are, Illumina, Inc., Abcam plc., Thermo Fisher Scientific Inc., Zymo Research Corp, Active Motif Corporation, QIAGEN N.V., New England Biolabs, Inc., Merck KGaA, CellCentric, Eisai Co., Ltd. and Novartis AG.

Market Opportunities
The key opportunity for the players operating in the global epigenetics market lies in development of improved solutions that will assist epigenetic research process for varied applications such as drug development and oncology research. Increasing emphasis on improving the healthcare infrastructure in emerging countries such as China and India will create lucrative growth opportunities for the market in coming years.

Enquiry about Report@ https://www.qurateresearch.com/report/enquiry/HnM/QBI-CMR-HnM-54995

Epigenetics Market Segmentation:
By Product:
Enzymes
DNA-Modifying Enzymes
RNA-Modifying Enzymes
Protein-Modifying Enzymes

Kits
Bisulfite Conversion Kits
RNA Sequencing Kits
Chip-Seq Kits
5-HMC and 5-MC Analysis Kits
Whole-Genome Amplification Kits
Other Epigenetics Kits

Instruments and Consumables
Next-Generation Sequencers
Mass Spectrometers
Sonicators
QPCR
Other Epigenetics Instruments and Consumables

Reagents
Histones
Buffers
Antibodies
Primers
Magnetic Beads
Other Epigenetics Reagents

By Research Area:
Drug Discovery
Developmental Biology
Oncology
Other Research Areas

Buy This Report@ https://www.qurateresearch.com/report/buy/HnM/QBI-CMR-HnM-54995/

About Us:
Qurate Business Intelligence delivers unique market research solutions to its customers and help them to get equipped with refined information and market insights derived from reports. We are committed to providing best business services and easy processes to get the same. Qurate Business Intelligence considers themselves as strategic partners of their customers and always shows the keen level of interest to deliver quality.

Runwal Platinum,
Ramnagar Colony, Bavdhan,
Pune, Maharashtra, India-411021
https://www.qurateresearch.com/
IN +919881074592
info@qurateresearch.com

This release was published on openPR.